Enanta Pharmaceuticals Inc
$ 13.42
1.98%
21 Jul - close price
- Market Cap 382,671,000 USD
- Current Price $ 13.42
- High / Low $ 13.65 / 12.90
- Stock P/E N/A
- Book Value 4.01
- EPS -2.49
- Next Earning Report f
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.12 %
- ROE -0.59 %
- 52 Week High 17.15
- 52 Week Low 6.45
About
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.
Analyst Target Price
$21.17
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-11 | 2026-02-09 | 2025-11-17 | 2025-08-11 | 2025-05-12 | 2025-02-10 | 2024-11-25 | 2024-08-05 | 2024-05-06 | 2024-02-07 | 2023-11-20 | 2023-08-07 |
| Reported EPS | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 |
| Estimated EPS | -0.57 | -0.88 | -1.01 | -0.88 | -1.14 | -1.35 | -0.92 | -1.41 | -1.4 | -1.23 | -2.21 | -2.19 |
| Surprise | 0.12 | 0.46 | 0.14 | 0.03 | 0.08 | 0.3 | -0.44 | 0.34 | -0.07 | -0.35 | 0.88 | 0.33 |
| Surprise Percentage | 21.0526% | 52.2727% | 13.8614% | 3.4091% | 7.0175% | 22.2222% | -47.8261% | 24.1135% | -5% | -28.4553% | 39.819% | 15.0685% |
Next Quarterly Earnings
| Jul 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ENTA
2026-07-17 17:39:51
The article focuses on the enterprise value to EBIT forward ratio for Enanta Pharmaceuticals, Inc. (BX:9EP) as listed on the BX Swiss exchange. It highlights the financial metric's value, change, and percentage change over a specified period. The content appears to be a stub or a section of a larger financial data page on TradingView.
2026-07-15 00:13:31
The article provides financial data for Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), specifically focusing on its enterprise value to EBITDA forward. It indicates the stock market status as closed with no trades. The document highlights the data sources and copyright information for the financial and reference data presented.
2026-07-08 15:09:30
The article focuses on the enterprise value to EBIT forward for Enanta Pharmaceuticals, Inc. (DUS:9EP) as listed on the Dusseldorf Stock Exchange. It provides a financial overview, though no specific values are present, and highlights the company's listing within the Health Technology and Pharmaceuticals sector. The content appears to be a financial data page from TradingView.
2026-07-08 13:40:53
This page on TradingView provides financial information for Enanta Pharmaceuticals, Inc. (SWB:9EP), focusing on its enterprise value to forward EBITDA. The content is primarily an outline for financial data and analysis tools available on the platform, without detailed numerical figures or analytical insights here.
2026-07-08 11:39:54
This page provides financial data, specifically the Enterprise Value to EBITDA forward, for Enanta Pharmaceuticals, Inc. (9EP) traded on the Dusseldorf Stock Exchange. It appears to be a financial data snippet from TradingView, offering a quick overview without detailed analysis or figures in this excerpt.
2026-07-06 12:09:26
This page from TradingView displays financial information for Enanta Pharmaceuticals, Inc. (GETTEX:9EP), specifically focusing on its Enterprise Value to EBITDA forward metric. The content indicates that the market is currently closed, and no trades have occurred for this stock.
